Clinical Brief: Safety of Lipid-Lowering Therapies

This Brief summarizes four studies that examine the safety of HMG-CoA reductase inhibitors (statins). It also includes an analysis for MCOs by Steven R. Peskin, MD, MBA.


  • The Report of the National Lipid Association Statin Safety Task Force
  • International Studies on the Comparative Safety of Rosuvastatin